Development of a novel reporter gene assay to evaluate antibody-dependent cellular phagocytosis for anti-CD20 therapeutic antibodies

Development of a novel reporter gene assay to evaluate antibody-dependent cellular phagocytosis for anti-CD20 therapeutic antibodies

Greater than 100 monoclonal antibodies (mAbs) have been accepted by FDA. The mechanism of motion (MoA) includes in neutralization of a selected goal by way of the Fab area and Fc effector features by Fc area, whereas the latter embody complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC) and antibody-dependent mobile phagocytosis (ADCP). ADCP has been acknowledged one of the…

Read More
Use of non-TNF biologics for the treatment of neuro-Behçet's disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab

Use of non-TNF biologics for the treatment of neuro-Behçet’s disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab

Neurological issues of BD (neuro-Behçet’s illness [NBD]) are life-threatening and disabling manifestations. Neurological involvement happens in roughly 5% to 18% of sufferers with BD. Most sufferers with NBD reply nicely to glucocorticoids, cyclophosphamide, or anti-tumor necrosis elements (TNFs), however there are some resistant instances refractory to those medicine. This examine goals to summarize the present…

Read More